For research use only
| Cat No. | ABC-SC179Y |
| Product Type | Human iPSCs |
| Cell Type | Induced Pluripotent Stem Cell |
| Species | Human |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | IPSC |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Discover HighQC™ Human Induced Pluripotent Stem Cells derived from urine, offering solutions for research and regenerative medicine applications.
HighQC™ Human Induced Pluripotent Stem Cells, From urine of individuals are generated non-invasively from epithelial cells isolated from the urine of healthy donors using integration-free reprogramming techniques. These iPSCs express key pluripotency markers such as OCT4, NANOG, SSEA4, and TRA-1-60, maintain a normal karyotype, and possess the potential to differentiate into multiple cell types including neurons, cardiomyocytes, and hepatocytes. Each batch undergoes rigorous quality control, including sterility, mycoplasma, and pluripotency verification. Additionally, no viral contamination from HIV-1, HIV-2, HTLV-I, or HTLV-II has been detected. With safe sourcing and stable quality, these cells are ideal for disease modeling, drug screening, and regenerative medicine research.
| Species | Human |
| Cat.No | ABC-SC179Y |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Induced Pluripotent Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | IPSC |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human iPSCs |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Urine-derived iPSCs are suitable for personalized disease modeling, toxicology studies, high-throughput drug screening, and directed differentiation into various functional cell types, such as neurons, cardiomyocytes, and hepatocytes. Their non-invasive and easily accessible source makes them especially valuable for large-scale clinical sample collection, disease-specific research, biobanking, and the development of regenerative cell therapies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).